|
|
|
| Evaluation
of indeterminate |
||
| nodules |
||
|
|
|
|
|
|
|
|
|
|
| l | Risk assessment
using Bayesian analysis |
||||||||
| l | Uses nodule and
patient characteristics |
||||||||
| l | E.g.: age,
smoker, size, location,growth rate |
||||||||
| l | Determine
probability of malignancy (Pca) |
||||||||
| using likelihood
ratios (LR) |
|||||||||